Aripiprazole for treating irritability in children & adolescents with autism: A systematic review - Wikidata - awgldk - TriplyDB

Aripiprazole for treating irritability in children & adolescents with autism: A systematic review

Aripiprazole for treating irritability in children & adolescents with autism: A systematic review

http://www.wikidata.org/entity/Q26784199

about

Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder.Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

P2860

Q36808178-658F7AD4-17AA-4C67-92FF-10C5AFCCDF08 Q47564469-5012AF9E-50DB-4B93-8C46-5C8CAE5FA5B1

P2860

Aripiprazole for treating irritability in children & adolescents with autism: A systematic review

http://www.wikidata.org/entity/Q26784199

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Aripiprazole for treating irri ...... th autism: A systematic review

@ast

Aripiprazole for treating irri ...... th autism: A systematic review

@en

Aripiprazole for treating irri ...... th autism: A systematic review

@nl

type

label

Aripiprazole for treating irri ...... th autism: A systematic review

@ast

Aripiprazole for treating irri ...... th autism: A systematic review

@en

Aripiprazole for treating irri ...... th autism: A systematic review

@nl

prefLabel

Aripiprazole for treating irri ...... th autism: A systematic review

@ast

Aripiprazole for treating irri ...... th autism: A systematic review

@en

Aripiprazole for treating irri ...... th autism: A systematic review

@nl

P1433

Q26784199-55261781-1CAD-4BDC-AA86-46E91AAF7796

P1476

Q26784199-8AE192C3-4E96-4632-A576-B937AE00FBAE

P2093

Q26784199-0830D3B7-2836-4E6D-BA01-DD876CDE8D41

Q26784199-1ECACCB3-4F12-47DA-9845-E1451E77A8A8

Q26784199-6FC400D8-0076-4090-8924-C858DD06BC88

P275

Q26784199-08E0FC63-2BCC-4A4B-8F6C-ADBCFD45BF41

P2860

Q26784199-045D89CE-06AD-40B2-916D-B85E4AF5CE74

Q26784199-06777807-B0F5-4F00-8A37-E0E467B9E4ED

Q26784199-1362F9B6-7B69-4632-9EC6-0D35CABE281E

Q26784199-16F5511A-585C-4228-8EC2-7999D3CC3CB0

Q26784199-1E77FDC9-50C8-427C-9660-A64308526974

Q26784199-235DEE81-151F-4A74-BDD0-3CD779F515D6

Q26784199-2B0AB0FF-A5A2-420F-95B7-A8C7EE50E202

Q26784199-2B9657C0-BC22-4703-8331-18CA4AA5A40E

Q26784199-2EF398E8-A8AF-4337-8DB7-F8BC651F72B9

Q26784199-3096AF62-043A-4CF9-BE4F-426868D5ABD3

P304

Q26784199-EC325E37-E019-4005-BA6D-F4820EDBDE43

P31

Q26784199-5650B8EA-735B-488D-9BCE-70A24BF6F98C

Q26784199-66CE845B-84D4-4573-B02B-F9F440FDDC4C

Q26784199-CF22E1EB-9306-488C-A1C1-336F2EB8687C

P3181

Q26784199-1717DF3C-CE9A-4216-A522-B1668E153F78

P356

Q26784199-8149FC09-2D9B-45FF-88AF-1AE33B9F253F

P407

Q26784199-AABF7777-BC15-472E-912F-5FE16CFC62A0

P433

Q26784199-7C7743B5-9647-455A-99B2-37D9E24FD2C3

P478

Q26784199-ECCC60B8-A729-41C1-A5E2-466B563CAB2E

P5008

Q26784199-191ABF3C-A8C3-461F-AB76-88806B1EEFB3

P577

Q26784199-742FA0AF-9BA1-4AB2-834F-F8A67BD30178

Q26784199-9ED62167-15FE-4D6B-B593-68B7CC8EDDD5

P698

Q26784199-3C062740-1FC8-45B0-878F-9BA172F650EC

P921

Q26784199-1E3E4043-7534-4D76-88A0-A2F9F92E7D1C

Q26784199-7CE10120-4FAE-4266-BA8F-B7198DA5C24C

Q26784199-89A3B68B-6F35-4528-B871-D9B9643792BB

P932

Q26784199-F49C4E49-13FF-4C3F-A986-91A285C397AD

P3181

P356

0971-5916.166584

P1433

Indian Journal of Medical Research

P1476

Aripiprazole for treating irri ...... th autism: A systematic review

@en

P2093

Ahmad Ghanizadeh

http://www.w3.org/2001/XMLSchema#string

Nematollah Jaafari

http://www.w3.org/2001/XMLSchema#string

Sylvie Tordjman

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

Aripiprazole for autism spectrum disorders (ASD)

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Pharmacotherapy of autism spectrum disorders

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

Aripiprazole in autism spectrum disorders and fragile X syndrome.

A systematic review of medical treatments for children with autism spectrum disorders.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

P304

269-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

2330737

http://www.w3.org/2001/XMLSchema#string

P356

10.4103/0971-5916.166584

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26458342

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

P932

4669861

http://www.w3.org/2001/XMLSchema#string